NeedyMeds
A nonprofit clearinghouse of patient-assistance programs, coupons, and diagnosis-based funds, searchable by drug name.
Best for
Anyone facing a high cost for a specific brand-name medication.
Why Kave includes this
NeedyMeds is the most complete non-commercial index of manufacturer assistance programs, and it does not sell your search history to pharmacies. Kave prefers it over commercial coupon aggregators as the first stop because its listings state eligibility rules in full rather than showing a price and burying the conditions.
- Expected cost
- The database is free. The programs it lists range from free medication to fixed copays.
- Insurance requirement
- Varies by program. Many manufacturer programs require that you be uninsured or that your plan not cover the drug; copay cards typically require commercial insurance and exclude Medicare and Medicaid.
- Who qualifies
- Most manufacturer programs use an income limit between 200% and 500% of the Federal Poverty Level, plus proof of prescription.
- Where it is available
- Nationwide (United States)
- How you use it
- Online or by phone
- Languages
- English and Spanish
Limitations Kave wants you to know about
- Applications for manufacturer programs usually require a prescriber's signature and can take two to six weeks.
- Copay cards are generally unavailable to people on Medicare or Medicaid.
- Listings are aggregated, so confirm the current terms on the manufacturer's own page before applying.
Helpline staffed on weekdays.
Verification
Compiled by Kave on July 1, 2026 and link-checked. Not yet independently verified. Kave assembled this from the organisation’s own published material and confirmed the links resolve. No reviewer has confirmed the eligibility details against the source, so check them on the official site before you rely on them.
- Compiled
- July 1, 2026 (28 days ago)
- Next scheduled review
- September 29, 2026
- Reviewed by
- Not yet reviewed
Sources used
- NeedyMeds — read July 1, 2026
Kave quality score
87/100
Kave lists resources scoring 80 or above that also clear all four mandatory gates.
- Patient impact22/25
- Affordability or financial value18/20
- Transparency13.8/15
- Accessibility12/15
- Ease of use7.2/10
- Geographic reach5/5
- Institutional credibility4.4/5
- Privacy and data practices4.4/5
Geographic reach is deliberately worth only five points, so a strong local resource is not pushed out by a weak national one. Read the methodology.